The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer
- PMID: 39572460
- DOI: 10.1007/s00535-024-02170-3
The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer
Abstract
Background: A substantial portion of gastric cancer (GC) is linked to Epstein-Barr virus (EBV) infection. The characteristics of this viral genome, such as specific viral strains and large structural variations, influence the progression of diseases like nasopharyngeal carcinoma and hematological malignancy. However, the EBV genomes from GC have not been thoroughly characterized.
Methods: Our study involved 849 consecutive GC patients diagnosed at Nagoya City University Hospital, Japan (NCU cohort). We detected EBV from formalin-fixed, paraffin-embedded sections using a novel direct PCR-based rapid detection method. Additionally, we analyzed 142 EBV whole genomes (125 newly sequenced) from GC, comparing them with 205 genomes from other EBV-associated diseases.
Results: We identified 32 (3.8%) patients associated with EBVaGC in the NCU cohort. Moreover, the direct PCR identified several GC specimens containing EBV-infected lymphocytes or their follicles. The dominant viral strain in GC was type 1 EBV, prevalent in most parts of the world, and no GC-specific strain was identified. We found no significant associations between single-nucleotide variants in the viral genome and GC. Structural variations of the EBV genome were infrequent in GC (4 cases, 2.1%), contrasting with EBV-associated hematological malignancy, which frequently carries large deletions.
Conclusions: This study is the first to uncover the genomic variations of EBV in GC. While EBV is definitively linked to GC, the characteristics of its genomes do not strongly correlate with disease development or progression. Our findings on viral genomes supplement the current understanding of human genomes in EBVaGC.
Keywords: Epstein–Barr virus; Epstein–Barr virus-associated gastric cancer; Gastric cancer; Viral genome; Whole-genome sequencing.
© 2024. Japanese Society of Gastroenterology.
Conflict of interest statement
Declarations. Conflict of interest: Akira Satou received a research grant from Eisai Company. Other authors declare that they have no conflict of interest.
References
-
- Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396:635–48. https://doi.org/10.1016/s0140-6736(20)31288-5 . - DOI - PubMed
-
- Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39:1179–203. https://doi.org/10.1007/s10555-020-09925-3 . - DOI - PubMed - PMC
-
- Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9. https://doi.org/10.1038/nature13480 . - DOI
-
- He CY, Qiu MZ, Yang XH, et al. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med. 2020;10:353–62. https://doi.org/10.1002/ctm2.32 . - DOI - PubMed - PMC
-
- Ignatova E, Seriak D, Fedyanin M, et al. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer. 2020;23:951–60. https://doi.org/10.1007/s10120-020-01095-z . - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous